Hospital General Universitario de Elche -ko ikertzaileekin lankidetzan egindako argitalpenak (64)

2024

  1. Discovery of recessive effect of human polymerase δ proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells

    European Journal of Human Genetics, Vol. 32, Núm. 7, pp. 837-845

  2. Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

    Orphanet Journal of Rare Diseases, Vol. 19, Núm. 1

  3. Identification of new targets for glioblastoma therapy based on a DNA expression microarray

    Computers in Biology and Medicine, Vol. 179

  4. SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population

    Database : the journal of biological databases and curation, Vol. 2024

  5. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 293-318

2023

  1. MLH1-methylated endometrial cancer under 60 years of age as the “sentinel” cancer in female carriers of high-risk constitutional MLH1 epimutation

    Gynecologic Oncology, Vol. 171, pp. 129-140

  2. Presenilin 1 Modulates Acetylcholinesterase Trafficking and Maturation

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2022

  1. Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology

    Clinical and Translational Oncology, Vol. 24, Núm. 10, pp. 1924-1931

  2. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  3. Lynch-like Syndrome: Potential Mechanisms and Management

    Cancers, Vol. 14, Núm. 5

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1

  2. Clyta-daao chimeric enzyme bound to magnetic nanoparticles. A new therapeutical approach for cancer patients?

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-24

  3. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  4. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

2020

  1. CLyta-DAAO, free and immobilized in magnetic nanoparticles, induces cell death in human cancer cells

    Biomolecules, Vol. 10, Núm. 2

  2. Cell death mechanisms induced by CLytA‐DAAO chimeric enzyme in human tumor cell lines

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-25

  3. Clinical and Pathological Characterization of Lynch-Like Syndrome

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 368-374.e1

  4. Differential effects of IGF-1R small molecule tyrosine kinase inhibitors BMS-754807 and OSI-906 on human cancer cell lines

    Cancers, Vol. 12, Núm. 12, pp. 1-18

  5. Hereditary leiomyomatosis and renal cell cancer syndrome in spain: Clinical and genetic characterization

    Cancers, Vol. 12, Núm. 11, pp. 1-16

  6. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 5, pp. 1009-1018